Creative Medical Technology Holdings, Inc. (CELZ) stock
CELZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.47−0.01 (-2.16%)
Close on Nov 18, 2026Market cap $3.07MP/E –Yield –
Creative Medical Technology free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
No free cash flow figures for Creative Medical Technology
Creative Medical Technology has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?